BRIEF-Vectura says partner Sandoz receives Belgian approval for Airflusal Forspiro

Wed Feb 12, 2014 10:13am EST

Related Topics

Feb 12 (Reuters) - Vectura Group PLC : * Belgian regulatory authority confirm approval of airflusal forspiro * Partner sandoz has received Belgian marketing authorisation for Airflusal Forspiro for patients with asthma, copd * Receipt of the Belgian marketing authorisation by sandoz triggers a milestone payment to Vectura of E1.5 million * Source text for Eikon: * For more news, please click here

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.